Cargando…

Predicting clinical progression in multiple sclerosis after 6 and 12 years

BACKGROUND AND PURPOSE: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. METHODS: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years....

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, I., Eijlers, A. J. C., Popescu, V., Balk, L. J., Vrenken, H., Wattjes, M. P., Uitdehaag, B. M. J., Killestein, J., Geurts, J. J. G., Barkhof, F., Schoonheim, M. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590122/
https://www.ncbi.nlm.nih.gov/pubmed/30629788
http://dx.doi.org/10.1111/ene.13904
_version_ 1783429489132306432
author Dekker, I.
Eijlers, A. J. C.
Popescu, V.
Balk, L. J.
Vrenken, H.
Wattjes, M. P.
Uitdehaag, B. M. J.
Killestein, J.
Geurts, J. J. G.
Barkhof, F.
Schoonheim, M. M.
author_facet Dekker, I.
Eijlers, A. J. C.
Popescu, V.
Balk, L. J.
Vrenken, H.
Wattjes, M. P.
Uitdehaag, B. M. J.
Killestein, J.
Geurts, J. J. G.
Barkhof, F.
Schoonheim, M. M.
author_sort Dekker, I.
collection PubMed
description BACKGROUND AND PURPOSE: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. METHODS: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years. Disability was measured using the Expanded Disability Status Scale (EDSS); cognition was measured only at follow‐up using neuropsychological testing. Predictors of interest included EDSS score, baseline brain and lesion volumes and their changes over 2 years, baseline age, clinical phenotype, sex and educational level. RESULTS: Higher 6‐year EDSS score was predicted by early EDSS score and whole‐brain volume changes and baseline diagnosis of primary progressive MS (adjusted R (2) = 0.56). Predictors for 12‐year EDSS score included larger EDSS score changes and higher T1‐hypointense lesion volumes (adjusted R (2) = 0.38). Year 6 cognition was predicted by primary progressive MS phenotype, lower educational level, male sex and early whole‐brain atrophy (adjusted R (2) = 0.26); year 12 predictors included male sex, lower educational level and higher baseline T1‐hypointense lesion volumes (adjusted R (2) = 0.14). CONCLUSIONS: Patients with early signs of neurodegeneration and a progressive disease onset were more prone to develop both disability progression and cognitive dysfunction. Male sex and lower educational level only affected cognitive dysfunction, which remains difficult to predict and probably needs more advanced imaging measures.
format Online
Article
Text
id pubmed-6590122
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65901222019-07-08 Predicting clinical progression in multiple sclerosis after 6 and 12 years Dekker, I. Eijlers, A. J. C. Popescu, V. Balk, L. J. Vrenken, H. Wattjes, M. P. Uitdehaag, B. M. J. Killestein, J. Geurts, J. J. G. Barkhof, F. Schoonheim, M. M. Eur J Neurol Original Articles BACKGROUND AND PURPOSE: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. METHODS: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years. Disability was measured using the Expanded Disability Status Scale (EDSS); cognition was measured only at follow‐up using neuropsychological testing. Predictors of interest included EDSS score, baseline brain and lesion volumes and their changes over 2 years, baseline age, clinical phenotype, sex and educational level. RESULTS: Higher 6‐year EDSS score was predicted by early EDSS score and whole‐brain volume changes and baseline diagnosis of primary progressive MS (adjusted R (2) = 0.56). Predictors for 12‐year EDSS score included larger EDSS score changes and higher T1‐hypointense lesion volumes (adjusted R (2) = 0.38). Year 6 cognition was predicted by primary progressive MS phenotype, lower educational level, male sex and early whole‐brain atrophy (adjusted R (2) = 0.26); year 12 predictors included male sex, lower educational level and higher baseline T1‐hypointense lesion volumes (adjusted R (2) = 0.14). CONCLUSIONS: Patients with early signs of neurodegeneration and a progressive disease onset were more prone to develop both disability progression and cognitive dysfunction. Male sex and lower educational level only affected cognitive dysfunction, which remains difficult to predict and probably needs more advanced imaging measures. John Wiley and Sons Inc. 2019-02-02 2019-06 /pmc/articles/PMC6590122/ /pubmed/30629788 http://dx.doi.org/10.1111/ene.13904 Text en © 2019 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Dekker, I.
Eijlers, A. J. C.
Popescu, V.
Balk, L. J.
Vrenken, H.
Wattjes, M. P.
Uitdehaag, B. M. J.
Killestein, J.
Geurts, J. J. G.
Barkhof, F.
Schoonheim, M. M.
Predicting clinical progression in multiple sclerosis after 6 and 12 years
title Predicting clinical progression in multiple sclerosis after 6 and 12 years
title_full Predicting clinical progression in multiple sclerosis after 6 and 12 years
title_fullStr Predicting clinical progression in multiple sclerosis after 6 and 12 years
title_full_unstemmed Predicting clinical progression in multiple sclerosis after 6 and 12 years
title_short Predicting clinical progression in multiple sclerosis after 6 and 12 years
title_sort predicting clinical progression in multiple sclerosis after 6 and 12 years
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590122/
https://www.ncbi.nlm.nih.gov/pubmed/30629788
http://dx.doi.org/10.1111/ene.13904
work_keys_str_mv AT dekkeri predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT eijlersajc predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT popescuv predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT balklj predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT vrenkenh predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT wattjesmp predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT uitdehaagbmj predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT killesteinj predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT geurtsjjg predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT barkhoff predictingclinicalprogressioninmultiplesclerosisafter6and12years
AT schoonheimmm predictingclinicalprogressioninmultiplesclerosisafter6and12years